MOREPEN LABORATORIES
Back to Balance Sheet
|
MOREPEN LABORATORIES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹501 Cr | ₹402 Cr | ₹321 Cr | ₹456 Cr | ₹404 Cr |
What is the latest Total Current Liabilities ratio of MOREPEN LABORATORIES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹501 Cr |
| Mar2024 | ₹402 Cr |
| Mar2023 | ₹321 Cr |
| Mar2022 | ₹456 Cr |
| Mar2021 | ₹404 Cr |
How is Total Current Liabilities of MOREPEN LABORATORIES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹501 Cr | 24.53 | |
| Mar2024 | ₹402 Cr | 25.18 | |
| Mar2023 | ₹321 Cr | -29.64 | |
| Mar2022 | ₹456 Cr | 13.04 | |
| Mar2021 | ₹404 Cr | - | |
Compare Total Current Liabilities of peers of MOREPEN LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MOREPEN LABORATORIES | ₹4,842.1 Cr | 20.1% | 51.7% | 91.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹450,211.0 Cr | -3% | -4.1% | 16.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹228,303.0 Cr | 0.6% | 17.5% | 41.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,233.0 Cr | 1.7% | -0.6% | 35.5% | Stock Analytics | |
| CIPLA | ₹115,672.0 Cr | -2% | -0.7% | -4.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,533.5 Cr | -1.5% | -3.5% | -2.2% | Stock Analytics | |
MOREPEN LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MOREPEN LABORATORIES | 20.1% |
51.7% |
91.5% |
| SENSEX | -1.2% |
-1.2% |
-3.3% |
You may also like the below Video Courses